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Synchronous and Metachronous Thoracic 
Aortic Aneurysms in Patients With 
Abdominal Aortic Aneurysms: A Systematic 
Review and Meta-Analysis
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Daniel Caldeira , MD, PhD; Ruy Fernandes e Fernandes , MD; Luís Mendes Pedro , MD, PhD
BACKGROUND: The prevalence of thoracic aortic aneurysms (TAA) in patients with known abdominal aortic aneurysms (AAA) 
is not well known and understudied. Our aim was to conduct a systematic review and meta-analysis of the overall prevalence 
of synchronous and metachronous TAA (SM-TAA) in patients with a known AAA and to understand the characteristics of this 
sub-population.
METHODS AND RESULTS: We searched MEDLINE, EMBASE, and CENTRAL (Cochrane Central Register of Controlled Trials) 
from inception to November 2019 for all population-based studies reporting on the prevalence of SM-TAAs in a cohort of 
patients with AAA. Article screening and data extraction were performed by 2 authors and data were pooled using a random-
effects model of proportions using Freeman-Tukey double arcsine transformation. The main outcome was the prevalence 
of SM-TAAs in patients with AAAs. Secondary outcomes were the prevalence of synchronous TAAs, metachronous TAAs, 
prevalence of TAAs in patients with AAA according to the anatomic location (ascending, arch, and descending) and the differ-
ences in prevalence of these aneurysms according to sex and risk factors. Six studies were included. The pooled-prevalence 
of SM-TAA in AAA patients was 19.2% (95% CI, 12.3–27.3). Results revealed that 15.2% (95% CI, 7.1–25.6) of men and 30.7% 
(95% CI, 25.2–36.5) of women with AAA had an SM-TAA. Women with AAA had a 2-fold increased risk of having an SM-TAA 
than men (relative risk [RRs], 2.16; 95% CI, 1.32–3.55). Diabetes mellitus was associated with a 43% decreased risk of having 
SM-TAA (RRs, 0.57; 95% CI, 0.41–0.80).
CONCLUSIONS: Since a fifth of AAA patients will have an SM-TAA, routine screening of SM-TAA and their clinical impact should 
be more thoroughly studied in patients with known AAA.
Key Words: abdominal aortic aneurysms ■ meta-analysis ■ metachronous aortic aneurysms ■ synchronous aortic aneurysms  
■ thoracic aortic aneurysms
Aneurysmal disease is known nowadays to be a systemic, multifactorial, and unpredictable condi-tion with different causes, behaviors and presen-
tations which increase the complexity of its diagnosis, 
treatment, and outcomes.1,2
Abdominal aortic aneurysms (AAA) are by far the 
most common and studied aneurysms and screening 
strategies have shown to be effective, reducing the in-
cidence in aneurysm rupture rate and improvement of 
care in a cost-effective fashion.3
The presence of synchronous and metachronous 
aneurysms has been well described in the literature.4 
However, in contrast to synchronous peripheral aneu-
rysms which are frequently screened and reported, 
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the incidence and behavior of synchronous/meta-
chronous thoracic aortic aneurysms (SM-TAA) is 
underappreciated.4
In a previous study in our center, we found 
that 18.9% of patients submitted to Thoracic 
Endovascular Aortic Repair, had a synchronous or 
metachronous AAA.5 However, thoracic aortic an-
eurysms (TAA) in general, do not have a screening 
program to date and the incidence and prevalence 
of these aneurysms is underappreciated. Since 
rupture of TAAs in patients with a known AAA or 
following an AAA repair has been described,4,6,7 
better understanding of the prevalence of these 
synchronous/metachronous TAAs in patients with 
a known AAA might be crucial for patients, physi-
cians, and policy makers.
Our aim was to estimate the overall prevalence of 
synchronous and metachronous TAAs in patients with 
a known AAA.
METHODS
The Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses guidelines8 were fol-
lowed for reporting and design of this systematic 
review. The authors declare that all supporting data 
are available within the article (and its online supple-
mentary files).
Eligibility Criteria
We included all cohort studies, either prospective 
or retrospective, reporting on the prevalence of tho-
racic aortic aneurysms in a population of patients with 
known abdominal aortic aneurysm, irrespective of the 
diagnostic method used. We accepted the definition of 
AAA or TAA provided by the studies. We defined syn-
chronous aneurysms as occurring concomitantly and 
metachronous aneurysms if the diagnosis of a new 
TAA occurred 2  years after the initial AAA diagnosis 
and no TAA was present initially.
There were no date or language restrictions. Animal 
studies were not included.
Papers were excluded if they did not specify the 
specific number of SM-TAA. If the same population 
was described in 2 papers 1 of them was excluded to 
not duplicate events. Papers were also excluded if the 
studied population (the denominator) included patients 
without AAA.
Information Sources and Search Method
We searched EMBASE, MEDLINE, and CENTRAL 
(Cochrane Central Register of Controlled Trials), from 
inception to November 2019. We also cross-checked 
references and consulted specialists for additional 
potential studies. The search strategy is detailed in 
Table S1.
The search results were cross-checked, and dupli-
cates were eliminated.
Study Selection, Data Collection Process, 
and Synthesis
Two authors (R.G.M. and A.L.) independently screened 
the titles and abstracts that yielded from the search. 
Full-text papers were also independently assessed 
by both authors and disagreements were resolved by 
consulting with a third author (G.D.).
After the final search result, data were inde-
pendently extracted by 2 authors (R.G.M. and A.L.) 
using a pre-design report form and uploaded onto a 
table sheet after cross-checking.
Data retrieved included: study publication data 
(authors, date, journal), population studied (years of 
the study and respective centers), study site, number 
of participants with known AAA, number of patients 
with SM-TAA and AAA, demographics (age, sex, risk 
CLINICAL PERSPECTIVE
What Is New?
• We found that 19.2% of patients with abdomi-
nal aortic aneurysm have a synchronous or me-
tachronous thoracic aortic aneurysm.
• Women have a 2-fold higher risk of having a 
synchronous or metachronous abdominal and 
thoracic aortic aneurysm.
• Diabetes mellitus is associated with a 43% 
decreased risk of having a synchronous or 
metachronous abdominal and thoracic aortic 
aneurysm.
What Are the Clinical Implications?
• Routine screening of synchronous/metachro-
nous thoracic aortic aneurysms and their 
clinical impact should be more thoroughly stud-
ied in patients with known abdominal aortic 
aneurysms.
• Differences in prevalence found between men 
and women might explain, in part, why women 
have worse outcomes following abdominal aor-
tic aneurysm repair.
Nonstandard Abbreviations and Acronyms
CENTRAL Cochrane Central Register of 
Controlled Trials
SM-TAA synchronous and metachronous  
thoracic aortic aneurysms




 http://ahajournals.org by on O
ctober 26, 2020
J Am Heart Assoc. 2020;9:e017468. DOI: 10.1161/JAHA.120.017468 3
Gouveia e Melo et al Synchronous/Metachronous Thoracic Aortic Aneurysms
factors), location of the TAA, diagnostic methods used, 
and definitions of TAA and AAA used.
The main outcome of interest was the overall prev-
alence of SM-TAA in patients with known AAA. The 
prevalence was defined as the number of existing 
TAAs at the time of the study in the population of pa-
tients with known AAA.
The secondary outcomes of interest included the 
prevalence of synchronous TAAs; the prevalence of 
metachronous TAAs; the prevalence of SM-TAA ac-
cording to the anatomic location and the difference in 
the prevalence of SM-TAA and AAA according to sex 
and other risk factors (smoking, hypertension, diabetes 
mellitus, family history of AAA/TAA, hyperlipidemia, 
and chronic obstructive pulmonary disease).
Statistical Analysis
We used the Open-Meta (Analyst) Software9 for 
quantitative analysis and to derive forest plots, when 
appropriate.
The results yielded by the data extraction were ex-
pressed in percentages for the prevalence of SM-TAA. 
The total number of individuals with known AAA was 
used as the denominator and the number of patients 
with SM-TAA and AAA as the numerator.
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A random-effects model was used to pool the 
data to account for the heterogeneity of the included 
studies.9 The random-effects model of DerSimonian 
and Laird was used by default as this approach is the 
simplest and most commonly used method for fitting 
the random effects model and is particularly useful for 
larger samples.10 Freeman-Tukey transformation (dou-
ble arcsine transformation) was used to adjust the data 
set to estimate the frequency of the events, limiting the 
CI among 0% to 100%.11 For subgroup sex analysis, 
we dichotomized the prevalence data and used male 
sex as the reference group and for subgroup risk fac-
tor analysis we used the group with AAA-only as the 
reference group, results were reported using risk ra-
tios [RRs] and 95% CIs. Statistical heterogeneity was 
assessed using I2, which was defined as low (25%), 
moderate (50%), or high (75%) according to Higgins 
and Thompson.12
Table 1. Study Details Including Cohort Origin and Definitions
Study
Years of the 
Study Location Cohort Origin
Definition of 






2004–2008 Stockholm, Sweden 
(Karolinska University 
Hospital)
Patients with AAA 

























2001–2006 Yokosuba, Japan 
(Cardiovascular Center)
Undergoing elective 
graft replacement for 
asymptomatic infrarenal 
AAA
NR Diameter >40 mm CT
Agricola  
et al, 201314
2013 Milan, Italy (San Raffaele 
Hospital)
Patients with AAA who 
underwent TE before 
surgery
NR Women: AAD 
>42 mm, AArchD 
>32; 

















2007–2017 Michigan, USA 
(Beaumont Health 
System)





AAA indicates abdominal aortic aneurysms; AAD, ascending aortic diameter; AArchD, aortic arch diameter; CT, computed tomography; DAD, descending 
aortic diameter; MR, magnetic resonance; NR, not reported; TAA, thoracic aortic aneurysm; and TE, transthoracic echocardiography.




Mean Age,  











Larsson et al, 
201115
354 74 (NR) 274 (77.4)/80 (22.6) 100 100; NR 12; 94; 6 62 (62)/38 (38)
Chaer et al, 
20124
1082 74.6 (9) 724 (66.9)/358 (33.1) 253 117; 136 NR 143 (68.5)/105 
(41.5)
Takigawa et al, 
201218
157 72.7 (7.5) 128 (82)/29 (18) 13 13; NR 2; 8; 3 NR
Agricola et al, 
201314
1305 NR 1034 (79.2)/271 
(20.8)
137 137; NR 52; NR; 85 66 (48)/71 (52)
Wallinder et al, 
201817
217 75 (NR) 0 (0)/217 (100) 67 NR; NR 8; 53; 2 NR/67 (100)
Dombrowski  
et al, 201916
218 74 (NR) 136 (62.4)/82 (37.6) 40 40; NR 19; 13; 8 20 (50)/20 (50)
AAA indicates abdominal aortic aneurysms; Arch, aortic arch; Asc, ascending thoracic aorta; CT, computed tomography; Desc, descending thoracic aorta; 
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Sensitivity analysis was performed according to the 
diagnostic method used (computed tomography [CT] 
scan or magnetic resonance/magnetic resonance-an-
giogram versus transthoracic echocardiography), to 
the definition for AAA used (only patients admitted 
for AAA repair versus all patients with an abdominal 
aortic diameter ≥3 cm) and type of patients included 
(both men and women versus only women).
Risk of Bias
We adapted and used the Critical Appraisal Skills 
Program cohort study checklist to assess for risk of 
bias, in which we categorized 9 items as having high, 
unclear, or low risk of bias.13 Two authors (R.G.M. and 
A.L.) independently assessed each included paper. The 
overall risk of bias for each study was divided as high- 
or low-risk, with high-risk studies considered those in 
which at least 2 items were assessed at a high risk of 
bias, or where >3 items were rated as unclear.
RESULTS
Included Studies
The search yielded 3563 papers which resulted in 3197 
articles after duplicates were removed. After title and 
abstract screening, 44 papers were included in the full-
text assessment. Of these, 6 articles were included in 
the review.4,14–18 The reasons for exclusion of the remain-
der 38 full-text articles assessed are detailed in Figure 1.
Study Characteristics and Demographic 
Data
Overall, 3333 patients with known AAA were included. 
Of these, 610 were found to have an SM-TAA.
Definitions of both AAA and TAA varied across stud-
ies (Table 1). Four papers4,15–17 defined AAA as an in-
crease in the aortic diameter ≥30 mm and 2 papers14,18 
did not give precise definition of AAA. However, both of 
these later studies included patients who were undergo-
ing elective AAA repair, so we can assume the definition 
to be a diameter of, at least 50 mm.14,18,19 The diagnos-
tic method of TAA also varied: CT in 4 studies15–18; CT, 
magnetic resonance, or magnetic resonance-angio-
gram in one,4 and transthoracic echocardiography in 
another.14 Specific demographic data, including risk 
factors, for all participants in both groups (synchro-
nous/metachronous and only AAA patients) were only 
detailed in 2 studies.4,16 Mean age in the total cohort 
varied between 72.5 and 75 years. Most patients in the 
cohort were men, except for the paper by Wallinder et 
al17 which only analyzed female patients (Table 2).
Figure 2. Forest plot analyzing the prevalence of synchronous/metachronous thoracic aortic aneurysm in patients with 
known abdominal aortic aneurysm.
AAA indicates abdominal aortic aneurysm; and SM-TAA, synchronous/metachronous thoracic aortic aneurysm.
Figure 3. Forest plot analyzing the prevalence of synchronous thoracic aortic aneurysm in patients with known abdominal 
aortic aneurysm.
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Only 1 paper4 provided with individualized data for 
both synchronous and metachronous TAAs, 4 pa-
pers14–16,18 only reported on synchronous TAAs and 
another included both synchronous and metachronous 
TAAs but did not report the specific number of each.17
Three papers provided the indications for chest 
imaging: in the Agricola et al14 study the reason was 
to measure the ascending aorta and aortic arch 
diameter and in the other 2 studies the majority of 
patients performed a chest CT for non-aortic re-
lated problems, mostly for pulmonary indications 
(74% in Chaer et al4 and 68% in Dombrowski et al16). 
Information on specific aortic diameter of the TAAs 
was only available in 2 studies.4,17 In the Wallinder 
et al17 study, one ascending aortic aneurysm had 
≥60 mm and 14 descending aortic aneurysms had 
≥55 mm leading to 13 of the patients having under-
gone repair. In the Chaer et al4 study they reported 
that 61 of 253 patients underwent repair, ruptured, 
or had a TAA >55 mm, and 13 patients died from a 
ruptured TAA. Mortality from TAA was not described 
in any other paper.
Risk of Bias
Overall, the risk of bias was considered to be high. The 
main source of risk of bias was the absence of adjust-
ing for key risk factors, which occurred in all studies, 
such as age, smoking, and hypertension. Additional 
sources of risk of bias were: the selective recruitment 
of patients undergoing AAA repair in the studies by 
Agricola et al14 and Takigawa et al,18 rather than in-
cluding every patient with AAA (ie, diameter ≥30 mm); 
and in the way the outcome (prevalence of TAA) was 
measured in the study by Agricola et al,14 which used 
transthoracic echocardiography only (Figure S1).
Prevalence of Synchronous/
Metachronous TAA in Patients With 
Known AAA
Overall, we found that 19.2% of patients with AAA had 
an SM-TAA (95% CI, 12.3–27.3; I2=96%; 6 studies; 
3333 participants)—Figure 2.
Individualized Prevalence of Synchronous 
and Metachronous TAA in Patients With 
Known AAA
The prevalence of synchronous TAA in patients with 
known AAA was 14.6% (95% CI, 0.09–20.9; I2=94%; 
5 studies;, 3116 participants)—Figure 3. Only the study 
from Chaer et al4 specified the number of metachro-
nous TAAs in patients with known AAA and found a 
prevalence of 12.7%.
Figure 4. Forest plot analyzing the prevalence of synchronous/metachronous ascending thoracic aortic aneurysm in 
patients with known abdominal aortic aneurysm.
AAA indicates abdominal aortic aneurysm; and SM-ascTAA: synchronous/metachronous ascending thoracic aortic aneurysm.
Figure 5. Forest plot analyzing the prevalence of synchronous/metachronous descending thoracic aortic aneurysm in 
patients with known abdominal aortic aneurysm.
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Prevalence of Synchronous/
Metachronous TAA in Patients With 
Known AAA According to Anatomic 
Location
The prevalence of SM-TAA in patients with known AAA 
according to the anatomic location of the TAA was 4% in 
the ascending thoracic aorta (95% CI, 2.4–5.7; I2=69%; 
5 studies; 2251 participants)—Figure  4; 14.1% in the 
descending thoracic aorta (95% CI, 4.7–27.3; I2=96%; 
4 studies; 946 participants)—Figure 5 and 2.8% involv-
ing the aortic arch (95% CI, 0.9–5.5; I2=87%; 5 studies; 
2251 participants)—Figure 6.
Prevalence and Risk of Synchronous/
Metachronous TAA in Patients With 
Known AAA According to Sex
We found that 15.2% of male patients with AAA had 
an SM-TAA (95% CI, 7.1–25.6; I2=97%; 4 studies; 2168 
participants)—Figure 7. In female patients, the preva-
lence was higher: 30.7% of female patients with AAA 
had an SM-TAA (95% CI; 25.2–36.5; I2=71%; 5 studies; 
1008 participants)—Figure 8.
Comparing both groups, women with AAA had a 
2-fold increased risk of having SM-TAA compared with 
men with AAA (RRs, 2.16; 95% CI, 1.32–3.55; I2=90%; 
4 studies; 2168 participants)—Figure 9.
Risk of Synchronous/Metachronous TAA 
in Patients With Known AAA According to 
Other Risk Factors
Information on risk factors in both groups (SM-TAA 
and only AAA patients) was only available in 2 stud-
ies.4,16 Overall, diabetes mellitus was associated with a 
43% decreased risk of having SM-TAA and AAA (RRs, 
0.57; 95% CI, 0.41–0.80; I2=0%; 2 studies; 1007 par-
ticipants)—Figure  10. All other identified risk factors: 
smoking; hypertension; chronic obstructive pulmonary 
disease; family history of aortic aneurysm; and hyper-
lipidemia were not associated with an increased or de-
creased risk of having an SM-TAA and AAA (Table 3).
Sensitivity Analysis
To analyze the impact of using different diagnostic 
methods (namely transthoracic echocardiography), dif-
ferent definitions for AAA and only including female pa-
tients in the study, we performed a sensitivity analysis 
evaluating these effects (Table 4). Excluding the paper 
from Agricola et al,14 which used transthoracic echocar-
diography as the diagnostic method to screen for TAAs 
and screened only for ascending and arch aneurysms, 
showed an increase in the prevalence (19.2% versus 
21.5%). However, when analyzing according to the ana-
tomic location the prevalence remained the same on 
ascending TAAs and was lower on arch TAAs (2.8% 
Figure 7. Forest plot analyzing the prevalence in men of synchronous/metachronous thoracic aortic aneurysm in patients 
with known abdominal aortic aneurysm.
AAA indicates abdominal aortic aneurysm; and SM-TAA, synchronous/metachronous thoracic aortic aneurysm.
Figure 6. Forest plot analyzing the prevalence of synchronous/metachronous thoracic aortic arch aneurysm in patients 
with known abdominal aortic aneurysm.
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versus 1.9%). Also, when we only included papers using 
a definition of ≥30 mm4,15–17 for AAAs the prevalence of 
SM-TAA also increased (19.2% versus 25%).
DISCUSSION
The main findings of this review were: (1) the overall 
prevalence of SM-TAA in patients with a known AAA 
was 19.2% (95% CI, 12.3–27.3) and (2) the prevalence 
of SM-TAA was higher in women—30.7% (95% CI, 
25.2–36.5) versus 15.2% (95% CI, 7.1–25.6)—with a 
2-fold increase in risk.
These findings are surprising as almost a fifth of 
every patient with an AAA will have a TAA and that 
number increases to almost a third in women.
Screening strategies for AAA with an abdominal 
ultrasound have shown to be effective, reducing the 
incidence in aneurysm rupture rate and improvement 
of care in a cost-effective fashion.3 Contrary to AAAs, 
implementing a screening strategy for TAAs is difficult, 
since for an accurate diagnosis, a chest CT is usually 
necessary. Transthoracic echocardiography might 
find some but certainly not all TAAs, especially in the 
descending thoracic aorta. We found this in our sen-
sitivity analysis: the prevalence increased (19.2% ver-
sus 21.5%) when we excluded the study from Agricola 
et al.14 In fact, in this latter study,14 which used only 
transthoracic echocardiography to screen for TAAs, 
the prevalence described for synchronous TAAs in pa-
tients with known AAA was only 10.5%, which is prob-
ably because of the fact that descending TAAs were 
not screened (Table 4).
The absence of a timely diagnosis has led to a lot 
of TAAs passing undiagnosed until a complication oc-
curs, such as rupture, which is usually fatal.20,21 A TAA 
diagnosed before rupture is a potential life saved and 
this is usually made accidentally. We found that 19.2% 
of AAAs have an SM-TAA, this means that screening 
every patient with a known AAA with a chest CT might 
be useful. Moreover, death attributable to rupture of 
other aneurysms, such as TAAs, is already a problem 
recognized in long-term follow-up of AAA repair.4,6,7,22,23
Currently, there are no clear indications in the current 
Society of Vascular Surgery guidelines19 about full aor-
tic imaging when an AAA is diagnosed. Although more 
research is needed to demonstrate cost-effectiveness 
and the real impact of these SM-TAA, we believe TAA 
screening in patients with a known AAA should probably 
become common practice since 19.2% is not negligible.
The difference found between male and female 
sex is striking. It has been known that women have a 
lower threshold for aneurysm rupture and have worse 
outcomes after AAA repair, even when operated at 
smaller diameters.24,25 No one has yet clearly under-
stood why this occurs. The higher prevalence of syn-
chronous/metachronous thoracic and abdominal aortic 
Figure 9. Forest plot analyzing relative risk of female sex comparing with male sex on the prevalence of synchronous 
thoracic aortic aneurysm in patients with known abdominal aortic aneurysm.
AAA indicates abdominal aortic aneurysm; and SM-TAA, synchronous/metachronous thoracic aortic aneurysm.
Figure 8. Forest plot analyzing the prevalence in women of synchronous/metachronous thoracic aortic aneurysm in 
patients with known abdominal aortic aneurysm.
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aneurysms in women, might indicate that aneurysm 
disease has a different pathophysiology in the female 
sex, with a different and probably more aggressive and 
systemic behavior than in men. This might be one of 
the causes for these worse long-term outcomes found 
in women. Understanding this fact might lead us to in-
crease our diagnostic suspicion for synchronous and 
metachronous TAAs and lead us to better surveillance 
and ultimately improved care.
Because of lack of data, we were not able to an-
alyze in-depth other risk factors which might be pre-
dictive of higher prevalence of SM-TAA. We found 
diabetes mellitus to be negatively associated with the 
risk of having SM-TAA and AAA, however, this data 
were only available in 2 studies,4,16 which limits our 
findings. In the paper from Chaer et al4 positive pre-
dictors of SM-TAA were Black race; family history of 
TAA; hypertension; and obesity; and negative predic-
tors were diabetes mellitus, infra-renal location of the 
AAA; and smoking.
This review has some limitations, the difference in 
study designs on diagnostic method and definitions of 
both AAA and TAAs brings some clinical and possibly 
statistical heterogeneity to our results in general. The 
fact that the data retrieved was not age-standardized 
also limits our findings, and explains, at least, par-
tially, the statistical heterogeneity. The lack of data 
about risk factors in both groups (synchronous and 
AAA-only patients), such as smoking or hyperten-
sion, limited our analysis on possible confounding or 
predictive factors for the presence of SM-TAA. Other 
important data that were not available across all stud-
ies was the size of the TAAs found, the number of 
TAAs that ruptured, and their mortality before repair, 
which limits our analysis about risk and the prognosis 
of these aneurysms.
Further studies are needed to understand the clini-
cal behavior of synchronous and metachronous TAAs 
in AAA patients (including their morbidity and mortal-
ity), what is the true impact of screening patients with 
an AAA with a chest CT, to assess the cost-effective-
ness of such a screening program and to understand 
their relationship with the female sex.
A feasible observational study would be to compare 
2 time periods: pre- and post-SM-TAA screening with 
a chest CT in all patients with a known AAA to address 
the impact of screening in the number of treatable/near 
treatable TAAs and the number of preventable ruptured 
TAAs and deaths. Also, using large registry data would 
be useful to identify other clinical characteristics that 
might be more common in patients with synchronous 
or metachronous aortic aneurysms.
CONCLUSIONS
This meta-analysis increases the evidence about the 
presence of synchronous/metachronous TAA in pa-
tients with known AAA. The higher prevalence of these 
aneurysms in women is striking and might explain one 
of the aspects why worse outcomes on follow-up of 
AAA are observed in women and shows the impor-
tance of aortic screening in women.
To improve short- and long-term outcomes after 
AAA repair, the authors recommend that routine 
screening of synchronous and metachronous TAAs 
and their clinical impact should be more thoroughly 
studied, since 19.2% of AAAs with an SM-TAA is not a 
negligible number.
Table 3. Relative Risk of Having a Synchronous TAA and 
AAA Compared With Patients With AAA Only Across the 
Different Risk Factors
Risk Factor Relative Risk
Diabetes mellitus 0.57 (95% CI, 0.41–0.80; I2=0%; 
2 studies; 1007 participants)
Smoking 0.97 (95% CI, 0.85–1.10; I2=62%; 
2 studies; 1007 participants)
Hypertension 1.01 (95% CI, 0.94–1.01; I2=70%; 
2 studies; 1007 participants)
Hyperlipidemia 1.10 (95% CI, 0.89–1.3; I2=58%; 
2 studies; 1007 participants)
COPD 1.09 (95% CI, 0.93–1.28; I2=0%; 
2 studies; 1007 participants)
Family history of AAA/TAA 2.37 (95% CI, 0.97–5.77; I2=35%; 
2 studies; 1007 participants)
AAA indicates abdominal aortic aneurysm; COPD, chronic obstructive 
pulmonary disease; and TAAs, thoracic aortic aneurysms.
Figure 10. Forest plot analyzing relative risk of diabetes mellitus on the prevalence of synchronous thoracic aortic 
aneurysm in patients with known abdominal aortic aneurysm.
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Table S1. Research strategy. 
 
1. Exp Aortic Aneurysm, Thoracic/ 
2. Exp Aneurysm, Ruptured/ 
3. ((thoracoabdominal or thoraco-abdominal or thorax or thoracic) adj3 (aneurysm or 
dilated or ectasia) adj3 (aorta or aortic)).ti,ab,kw. 
4. 1 or 2 or 3 
5. Incidence/ or incidence.ti.ab.kw. 
6. Epidemiologic studies/ 
7. Cohort studies/ or cohort.ti.ab.kw. 
8. Prevalence/ or prevalence.ti.ab.kw 
9. 5 or 6 or 7 or 8 
10. 4 and 9 
11. Exp animals/ not humans.sh. 
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Figure S1. Risk of Bias – CASP cohort study checklist. 
 
 
Original CASP items Adapted CASP items Reasons for downgrading 
1.Did the study address a clearly 
focused issue?  
1.Did the study address a clearly focused issue?  
2.Was the cohort recruited in an 
acceptable way?  
2.Was the cohort recruited in an acceptable way? Not including every AAA with a diameter equal 
or higher than 30mm 
3.Was the exposure accurately 
measured to minimise bias?  
3.Was the exposure accurately measured to 
minimise bias? 
No clear explanation of how the diagnosis of AAA 
was obtained 
4.Was the outcome accurately 
measured to minimise bias?  
4.Was the outcome accurately measured to 
minimise bias? 
Did not use either chest MR or CT to diagnose a 
TAA 
5. (a) Have the authors identified all 
important confounding factors?  
5. (a) Have the authors identified all important 
confounding factors – age, smoking, hypertension 
These risk factors have not been identified and 
quantified in the overall cohort and outcome 
group 
5. (b) Have they taken account of the 
confounding factors in the design 
and/or analysis?  
5. (b) Have they taken account of the confounding 
factors in the design and/or analysis? 
No adjustment has been made for confounding 
factors (age, smoking, hypertension) 
6. (a) Was the follow up of subjects 
complete enough?  
Not used – not aplicable  
6. (b) Was the follow up of subjects 
long enough?  
Not used – not aplicable  
7. What are the results of this study?  Not used – not applicable (open question format)  
8. How precise are the results?  Not used – not applicable (open question format)  
9. Do you believe the results?  9. Do you believe the results? No clear definition of TAA and methods used for 
diagnosis are provided 
10. Can the results be applied to the 
local population?  
10. Can the results be applied to the local 
population? 
The population is not a valid cohort for AAA 
patients in a hospital/community setting 
11. Do the results of this study fit 
with other available evidence?  
11. Do the results of this study fit with other 
available evidence? 
The results are not in concordance with the overall 
available data regarding synchronous TAA and 
AAA 
12. What are the implications of this 
study for practice?  
Not used – not applicable (open question format)  
 
Risk of Bias using CASP cohort study checklist13. H: High risk of bias; U: Unclear risk of bias; 
L: Low risk of bias. This tool was adapted from the CASP cohort study checklist, in which we 
used 9 out of the 14 original items. The table below shows the changes made and what was 
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